Public Funding for Catalent U.K. Swindon Zydis Limited

To develop a formulation roadmap and integrated manufacturing process for the Zydis technology platform to aid the product development and improved clinical efficacy of drugs with otherwise poor pre-gastric absorption.

To develop a robust, reliable decision making tool for mapping and predicting the most appropriate absorption enhancers for pregastric delivery of different types of drugs, to optimise the formulation during the development of oral dissolving tablets (ODTs) and reduce empirical selection.